ASPC 2019 Congress on CVD Prevention
Avatar

Newer Insights Into Why the SGLT2s Reduce Heart Failure in Patients With Diabetes

By ASPC 2019 Congress on CVD Prevention FEATURING Robert Chilton
By ASPC 2019 Congress on CVD Prevention FEATURING Robert Chilton
0 views
August 9, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

46:20
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two In…

Feat. S. Shadid

Featured Video

46:20
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two In…

Feat. S. Shadid

Recommended

AUTOPLAY
16:57
William White

Ambulatory Blood Pressure Monitoring

64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
26:11
13th Orange County Symposium for Cardiovascular Disease Prevention

Update on Calcium Screening and CTA: Role in Prevention

Feat. M. Budoff
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
03:27
The Online Cardiac Catheterization Casebook

Trouble with the LAD during Anterior STEMI

Feat. M. Kern
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
42:28
Scripps Health

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Feat. M. Budoff
59:01
The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross
18:43
Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue
61:49
Obafemi Awolowo University

Management of Heart Failure

Feat. O. A. Akinyele
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
19:16
The Texas Heart Institute

Role of Coronary Calcification and Risk Stratification

Feat. E. Hernandez
08:44
AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston
14:50
AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray
24:02
Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus
19:24
National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
34:20
Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester
21:34
Canadian Collaborative Research Network

Should Colchicine Become Standard Therapy for CAD?

Feat. P. Ridker
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald